JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GREENBERG, L. A.
Right arrow Articles by LESTER, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by GREENBERG, L. A.
Right arrow Articles by LESTER, D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 88, Issue 1, 87-98, 1946
Copyright © 1946 by American Society for Pharmacology and Experimental Therapeutics


THE METABOLIC FATE OF ACETANILID AND OTHER ANILINE DERIVATIVES

I. MAJOR METABOLITES OF ACETANILID APPEARING IN THE URINE

LEON A. GREENBERG 1 and DAVID LESTER 1

1 From the Laboratory of Applied Physiology, Yale University

1. The present theories of the metabolism of acetanilid in man are conflicting. As the first step toward clarification a quantitative study was made of the major metabolites appearing in the urine.

2. Seventy to 90 per cent of the acetanilid administered appeared in the urine as conjugated p-aminophenol.

3. There was no free p-aminophenol.

4. Of the total p-aminophenol excreted, as determined in one experiment, 4 per cent consisted of the N-acetyl conjugate and 96 per cent as an hydroxy conjugate. The major portion of N-acetyl-p-aminophenol was excreted in the first few hours after administration.

5. Conjugated aniline was excreted to the extent of 0.2 to 0.6 per cent of the amount of acetanilid administered and mainly during the first 4 hours.

6. There was no free aniline.

7. There was no 2-benzoxazolone.

8. Azo compounds appeared in the urine in an amount corresponding to about 0.5 per cent of the acetanilid administreed.

Submitted on May 27, 1946




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
P. J. Murphy
The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 1, 1909-1958
Drug Metab. Dispos., January 1, 2008; 36(1): 1 - 5.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1946 by the American Society for Pharmacology and Experimental Therapeutics.